United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

News provided by

May 15, 2012, 08:24 ET

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

http://www.reportlinker.com/p0862101/United-States-Neurology-Devices-Market-Outlook-to-2018---Interventional-Neurology-Neurological-Diagnostic-Equipment-Neurostimulation-Devices-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

GlobalData's new report, "United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the United States Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the United States Neurology Devicesmarket.

- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cyberonics, Inc., DePuy, Inc., Stryker Corporation and others.

Reasons to buy

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the United States Neurology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents1 Table of Contents 21.1 List of Tables 101.2 List of Figures 132 Introduction 152.1 What is This Report About? 153 Neurology Devices In United States 163.1 Neurology Devices, Market Segmentation 163.2 Neurology Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 173.3 Neurology Devices Market, United States, Revenue Mix ($m), 2011 193.4 Neurology Devices Market, United States, Category Contribution (%), 2011 203.5 Neurology Devices, United States, Company Share (2010-2011) 274 CSF Management In United States 294.1 CSF Management, Market Segmentation 294.2 CSF Management Market, United States, Revenue Mix ($m), 2011 304.3 CSF Management Market, United States, Segment Contribution (%), 2011 314.4 CSF Management Overall Revenue, (2004-2018) 324.5 CSF Management Overall Volume (2004-2018) 364.6 CSF Management Average Price (2004-2018) 384.7 CSF Management Distribution Share (2010-2011) 394.8 CSF Management, United States, Company Share (2010-2011) 405 Interventional Neurology In United States 425.1 Interventional Neurology, Market.Segmentation 425.2 Interventional Neurology Market, United States, Revenue Mix ($m), 2011 435.3 Interventional Neurology Market, United States, Segment Contribution (%), 2011 445.4 Interventional Neurology Overall Revenue, (2004-2018) 455.4.1 Embolic Systems Revenue (2004-2018) 495.4.2 Navigational Systems Revenue (2004-2018) 535.5 Interventional Neurology Overall Volume (2004-2018) 575.5.1 Embolic Systems Volume (2004-2018) 615.5.2 Navigational Systems Volume (2004-2018) 635.6 Interventional Neurology Average Price (2004-2018) 655.7 Interventional Neurology Distribution Share (2010-2011) 665.8 Interventional Neurology, United States, Company Share (2010-2011) 676 Neurological Diagnostic Equipment In United States 696.1 Neurological Diagnostic Equipment, Market.Segmentation 696.2 Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2011 706.3 Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2011 716.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018) 726.5 Neurological Diagnostic Equipment Overall Volume (2004-2018) 766.6 Neurological Diagnostic Equipment Average Price (2004-2018) 806.7 Neurological Diagnostic Equipment Distribution Share (2010-2011) 816.8 Neurological Diagnostic Equipment, United States, Company Share (2010-2011) 827 Neurostimulation Devices In United States 847.1 Neurostimulation Devices, Market Segmentation 847.2 Neurostimulation Devices Market, United States, Revenue Mix ($m), 2011 857.3 Neurostimulation Devices Market, United States, Segment Contribution (%), 2011 867.4 Neurostimulation Devices Overall Revenue, (2004-2018) 877.5 Neurostimulation Devices Overall Volume (2004-2018) 917.6 Neurostimulation Devices Average Price (2004-2018) 957.7 Neurostimulation Devices Distribution Share (2010-2011) 967.8 Neurostimulation Devices, United States, Company Share (2010-2011) 978 Neurosurgical Products In United States 988.1 Neurosurgical Products, Market Segmentation 988.2 Neurosurgical Products Market, United States, Revenue Mix ($m), 2011 998.3 Neurosurgical Products Market, United States, Segment Contribution (%), 2011 1008.4 Neurosurgical Products Overall Revenue, (2004-2018) 1018.5 Neurosurgical Products Overall Volume (2004-2018) 1058.6 Neurosurgical Products Average Price (2004-2018) 1078.7 Neurosurgical Products Distribution Share (2010-2011) 1078.8 Neurosurgical Products, United States, Company Share (2010-2011) 1089 Radiosurgery In United States 1109.1 Radiosurgery, Market Segmentation 1109.2 Radiosurgery Market, United States, Revenue Mix ($m), 2011 1119.3 Radiosurgery Market, United States, Segment Contribution (%), 2011 1129.4 Radiosurgery Overall Revenue, (2004-2018) 1139.5 Radiosurgery Overall Volume (2004-2018) 1179.6 Radiosurgery Average Price (2004-2018) 1199.7 Radiosurgery Distribution Share (2010-2011) 1199.8 Radiosurgery, United States, Company Share (2010-2011) 12010 Overview of Key Companies in United States Neurology Devices Market 12110.1 Medtronic, Inc. 12110.1.1 Company Overview 12110.1.2 Share in the United States Neurology Devices Market 12110.2 Boston Scientific Corporation 12210.2.1 Company Overview 12210.2.2 Share in the United States Neurology Devices Market 12210.3 St. Jude Medical, Inc. 12310.3.1 Company Overview 12310.3.2 Share in the United States Neurology Devices Market 12310.4 Cyberonics, Inc. 12410.4.1 Company Overview 12410.4.2 Share in the United States Neurology Devices Market 12410.5 DePuy, Inc. 12510.5.1 Company Overview 12510.5.2 Share in the United States Neurology Devices Market 12510.6 Stryker Corporation 12610.6.1 Company Overview 12610.6.2 Share in the United States Neurology Devices Market 12610.7 Accuray Incorporated 12710.7.1 Company Overview 12710.8 Integra LifeSciences Holdings Corporation 12710.8.1 Company Overview 12710.9 Cadwell Laboratories, Inc. 12710.9.1 Company Overview 12710.10 CareFusion Corporation 12810.10.1 Company Overview 12810.11 Elekta AB 12810.11.1 Company Overview 12810.12 Natus Medical Incorporated 12910.12.1 Company Overview 12910.13 B. Braun Melsungen AG 12910.13.1 Company Overview 12910.14 Nihon Kohden Corporation 13010.14.1 Company Overview 13010.15 Terumo Corporation 13010.15.1 Company Overview 13010.16 KARL STORZ GmbH & Co. KG 13010.16.1 Company Overview 13010.17 Christoph Miethke GmbH & Co. KG 13110.17.1 Company Overview 13110.18 Covidien plc 13110.18.1 Company Overview 13111 Neurology Devices Market Pipeline Products 13212 Financial Deals Landscape 14112.1 Acquisition 14112.1.1 Greatbatch Acquires NeuroNexus Technologies, Neurotechnology Company 14112.1.2 Baxter International Completes Acquisition Of Synovis Life Technologies For $325 Million 14212.1.3 NuVasive Completes Acquisition Of Impulse Monitoring For $80 Million 14412.1.4 Stryker Completes Acquisition Of Concentric Medical For $135 Million 14512.1.5 Zynex Completes Acquisition Of NeuroDyne Medical 14712.1.6 LecTec Completes Acquisition Of AxoGen In Reverse Acquisition 14912.1.7 Toshiba Medical Systems Completes Acquisition Of Vital Images For $273 Million 15012.2 Partnerships 15212.2.1 Sequent Medical Enter Into Licensing Agreement With Inceptus Medical For MicroBraid Technology 15212.2.2 GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 15312.2.3 Radiant Sage Forms Joint Venture With Radiological Associates 15412.2.4 NSVascular Enters Into Licensing Agreement With University of California 15513 Recent Developments 15613.1 Strategy And Business Planning 15613.1.1 Feb 27, 2012: Greatbatch Announces Engagement To Advance Medical Device Strategy 15613.1.2 Feb 22, 2012: Accelitech To Open First CyberKnife Cancer Center Within City Of Chicago 15613.1.3 Feb 09, 2012: Zynex Forms European Subsidiary 15713.1.4 Jan 31, 2012: Boston Scientific Announces New Asia-Pacific Organization 15713.1.5 Jan 21, 2012: CareFusion Opens Middle East Office In Dubai 15713.1.6 Jan 10, 2012: Lanx Announces Corporate Expansion 15813.1.7 Dec 19, 2011: Medical Centers Worldwide Adopt Both Accuray's CyberKnife And TomoTherapy Systems 15913.1.8 Dec 05, 2011: Integra LifeSciences Establishes First Office In Shanghai, China 15913.1.9 Dec 01, 2011: InVivo Therapeutics Executes Deal For New, World-Class Global Corporate Headquarters Including Research And cGMP Manufacturing Facilities 16013.1.10 Nov 09, 2011: Allied Minds Forms New Company Focused On Medtech Product Commercialization 16013.1.11 Nov 08, 2011: Allergan To Open New Research And Development Facility In New Jersey 16113.1.12 Nov 02, 2011: Accellent Opens New Manufacturing Plant In Penang, Malaysia 16113.1.13 Oct 13, 2011: Unisense Establishes US Headquarter 16213.2 Legal and Regulatory 16313.2.1 Mar 30, 2012: Medtronic Reaches Settlement Of Shareholder Class Action 16313.2.2 Jan 17, 2012: Levi & Korsinsky Announces Investigation Against Integra LifeSciences 16313.2.3 Dec 13, 2011: Medtronic Reaches Settlement With US Department of Justice 16313.2.4 Dec 07, 2011: Boston Scientific Receives Notice Of Deficiency From IRS 16313.2.5 Oct 14, 2011: Boston Scientific Welcomes Introduction Of Medical Device Regulatory Improvement Act In US Senate 16413.2.6 Aug 08, 2011: Faruqi & Faruqi Announces Investigation Against Zynex 16413.2.7 May 24, 2011: Jensen Law Firm Announces $10m Verdict Against Johnson & Johnson Unit For Toxic Motrin Reaction 16413.2.8 May 03, 2011: U.S. Senate Finance Committee Announces Investigation Against Medtronic 16513.2.9 Apr 25, 2011: St. Jude Medical Wins $2.3 Billion In Trade Secret Infringement Lawsuit Against Nervicon 16513.3 Product News 16613.3.1 Sep 26, 2011: Elekta To Showcase Its Products At 2011 ASTRO Meeting In Florida 16613.3.2 Aug 10, 2010: NKI To Present Two Research Studies On I-Portal NOTC System At Barany Society Conference 16613.3.3 May 05, 2010: Terumo Announces Its Program For The Global Embolization Symposium And Technologies (GEST) Meeting 16713.3.4 Mar 09, 2010: MIT Selects Elekta Neuromag To Explore Brain Function 16713.3.5 Mar 01, 2010: Integra Launches OSV II Lumbar And OSV II Low Flow Lumbar Self-Adjusting Valves 16813.3.6 Feb 23, 2010: Barnes-Jewish Hospital Treats More Patients With Elekta's Extend Program For Gamma Knife Perfexion 16913.4 Government and Public Interest 17013.4.1 Apr 18, 2012: Researchers Discover Non-Surgical Test For Brain Cancer 17013.4.2 Apr 16, 2012: Mechanical Tissue Resuscitation Technology Shows Promise: Wake Forest Baptist Medical Center 17013.4.3 Mar 30, 2012: CareFusion Showcases Solutions To Improve Operating Room Effectiveness At AORN Congress 2012 17113.4.4 Mar 21, 2012: Neuro Kinetics To Preview Updated I-Portal Technology & VEST Software At American Academy of Audiology Conference 17213.4.5 Mar 12, 2012: NeuroMetrix To Exhibit At 2012 Diabetic Foot Global Conference 17313.4.6 Mar 12, 2012: NeuroMetrix To Exhibit At 2012 Diabetic Foot Global Conference 17313.4.7 Mar 04, 2012: Study Shows Brain Flexibility, Gives Hope For Natural-Feeling Neuroprosthetics 17413.4.8 Feb 23, 2012: ZOLL Sponsors Latin America's First Symposium On Therapeutic Temperature Management 17513.4.9 Feb 10, 2012: EEG Pattern Reflects Brain's Shift Into Low-Energy, Protective Mode: MGH 17613.4.10 Feb 02, 2012: New Procedure Repairs Severed Nerves In Minutes, Restoring Limb Use In Days Or Weeks 17713.4.11 Jan 24, 2012: New Deep Brain Stimulation Device Shows Promising Results: University of Cincinnati 17813.4.12 Jan 20, 2012: CareFusion Provides Update On Voluntary Recall Of Neurological Monitoring Software And Devices 17913.4.13 Jan 20, 2012: New Imaging Techniques Prove Valuable Tools To Assess Stroke Risk: Vanderbilt University 17913.4.14 Jan 12, 2012: CSHL Team Introduces Automated Imaging To Greatly Speed Whole-Brain Mapping Efforts 18113.4.15 Jan 02, 2012: Schizophrenia Diagnosis Associated With Progressive Brain Changes Among Adolescents: Study 18213.4.16 Jan 02, 2012: Deep Brain Stimulation Shows Promising Results For Unipolar And Bipolar Depression: Study 18313.4.17 Dec 21, 2011: UCLA Neuroscientists Demonstrate Crucial Advances In 'Brain Reading' 18413.4.18 Nov 28, 2011: Functional Brain Pathways Disrupted In Children With ADHD 18513.4.19 Nov 25, 2011: Deymed Diagnostic To Participate In Arab Health 2012 Conference 18613.4.20 Nov 17, 2011: NREF And OREF Announce Creation Of Collaborative Spine Research Foundation To Fund Spine-Care Research 18613.4.21 Nov 13, 2011: Ultrathin Flexible Brain Implant Offers Unique Look At Seizures In NIH-Funded Research 18613.4.22 Nov 02, 2011: Lake Region Medical To Showcase New And Emerging Technologies At TCT Annual Meeting 2011 18714 Appendix 18914.1 Definitions of Markets Covered in the Report 19014.1.1 Neurology Devices 19014.2 Research Methodology 19414.3 Secondary Research 19414.4 Primary Research 19514.5 Models 19514.6 Forecasts 19614.7 Expert Panels 19614.8 GlobalData Consulting 19614.9 Contact Us 19614.10 Disclaimer 197

List of Tables

Table 1: Neurology Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 18Table 2: Neurology Devices Market, United States, Category Contribution (%), 2011 20Table 3: Neurology Devices, United States, Cross-Category Analysis, 2004-2018 22Table 4: Neurology Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011 24Table 5: Neurology Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 26Table 6: Neurology Devices, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 28Table 7: CSF Management Market, United States, Segment Contribution (%), 2011 31Table 8: CSF Management, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 33Table 9: CSF Management, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 35Table 10: CSF Management, United States, Volume (Units) by Segment, Historic, 2004-2011 36Table 11: CSF Management, United States, Volume (Units) by Segment, Forecast, 2011-2018 37Table 12: CSF Management, United States, Average Price ($), Historic, 2004-2011 38Table 13: CSF Management, United States, Average Price ($), Forecast, 2011-2018 38Table 14: CSF Management, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 39Table 15: CSF Management, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 41Table 16: Interventional Neurology Market, United States, Segment Contribution (%), 2011 44Table 17: Interventional Neurology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 46Table 18: Interventional Neurology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 48Table 19: Embolic Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 50Table 20: Embolic Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 52Table 21: Navigational Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 54Table 22: Navigational Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 56Table 23: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2004-2011 58Table 24: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2011-2018 60Table 25: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 61Table 26: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62Table 27: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 63Table 28: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 64Table 29: Interventional Neurology, United States, Average Price ($), Historic, 2004-2011 65Table 30: Interventional Neurology, United States, Average Price ($), Forecast, 2011-2018 65Table 31: Interventional Neurology, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 66Table 32: Interventional Neurology, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 68Table 33: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2011 71Table 34: Neurological Diagnostic Equipment, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 73Table 35: Neurological Diagnostic Equipment, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 75Table 36: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Historic, 2004-2011 77Table 37: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Forecast, 2011-2018 79Table 38: Neurological Diagnostic Equipment, United States, Average Price ($), Historic, 2004-2011 80Table 39: Neurological Diagnostic Equipment, United States, Average Price ($), Forecast, 2011-2018 80Table 40: Neurological Diagnostic Equipment, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 81Table 41: Neurological Diagnostic Equipment, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 83Table 42: Neurostimulation Devices Market, United States, Segment Contribution (%), 2011 86Table 43: Neurostimulation Devices, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 88Table 44: Neurostimulation Devices, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 90Table 45: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2004-2011 92Table 46: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018 94Table 47: Neurostimulation Devices, United States, Average Price ($), Historic, 2004-2011 95Table 48: Neurostimulation Devices, United States, Average Price ($), Forecast, 2011-2018 95Table 49: Neurostimulation Devices, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 96Table 50: Neurostimulation Devices, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 97Table 51: Neurosurgical Products Market, United States, Segment Contribution (%), 2011 100Table 52: Neurosurgical Products, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 102Table 53: Neurosurgical Products, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 104Table 54: Neurosurgical Products, United States, Volume (Units) by Segment, Historic, 2004-2011 105Table 55: Neurosurgical Products, United States, Volume (Units) by Segment, Forecast, 2011-2018 106Table 56: Neurosurgical Products, United States, Average Price ($), Historic, 2004-2011 107Table 57: Neurosurgical Products, United States, Average Price ($), Forecast, 2011-2018 107Table 58: Neurosurgical Products, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 107Table 59: Neurosurgical Products, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 109Table 60: Radiosurgery Market, United States, Segment Contribution (%), 2011 112Table 61: Radiosurgery, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 114Table 62: Radiosurgery, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 116Table 63: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2004-2011 117Table 64: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2011-2018 118Table 65: Radiosurgery, United States, Average Price ($), Historic, 2004-2011 119Table 66: Radiosurgery, United States, Average Price ($), Forecast, 2011-2018 119Table 67: Radiosurgery, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 119Table 68: Radiosurgery, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 120Table 69: Neurology Devices Market Pipeline Products 132Table 70: Greatbatch Acquires NeuroNexus Technologies, Neurotechnology Company 141Table 71: Baxter International Completes Acquisition Of Synovis Life Technologies For $325 Million 142Table 72: NuVasive Completes Acquisition Of Impulse Monitoring For $80 Million 144Table 73: Stryker Completes Acquisition Of Concentric Medical For $135 Million 145Table 74: Zynex Completes Acquisition Of NeuroDyne Medical 147Table 75: LecTec Completes Acquisition Of AxoGen In Reverse Acquisition 149Table 76: Toshiba Medical Systems Completes Acquisition Of Vital Images For $273 Million 150Table 77: Sequent Medical Enter Into Licensing Agreement With Inceptus Medical For MicroBraid Technology 152Table 78: GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 153Table 79: Radiant Sage Forms Joint Venture With Radiological Associates 154Table 80: NSVascular Enters Into Licensing Agreement With University of California 155

List of Figures

Figure 1: Neurology Devices, Market Segmentation 16Figure 2: Neurology Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 17Figure 3: Neurology Devices Market, United States, Revenue Mix ($m), 2011 19Figure 4: Neurology Devices Market, United States, Category Contribution (%), 2011 20Figure 5: Neurology Devices, United States, Cross-Category Analysis, 2004-2018 21Figure 6: Neurology Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011 23Figure 7: Neurology Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 25Figure 8: Neurology Devices, United States, Company Share (%), 2011 27Figure 9: CSF Management, Market Segmentation 29Figure 10: CSF Management Market, United States, Revenue Mix ($m), 2011 30Figure 11: CSF Management Market, United States, Segment Contribution (%), 2011 31Figure 12: CSF Management, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 32Figure 13: CSF Management, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 34Figure 14: CSF Management, United States, Volume (Units) by Segment, Historic, 2004-2011 36Figure 15: CSF Management, United States, Volume (Units) by Segment, Forecast, 2011-2018 37Figure 16: CSF Management, United States, Company Share (%), 2011 40Figure 17: Interventional Neurology, Market Segmentation 42Figure 18: Interventional Neurology Market, United States, Revenue Mix ($m), 2011 43Figure 19: Interventional Neurology Market, United States, Segment Contribution (%), 2011 44Figure 20: Interventional Neurology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 45Figure 21: Interventional Neurology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 47Figure 22: Embolic Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49Figure 23: Embolic Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 51Figure 24: Navigational Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 53Figure 25: Navigational Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 55Figure 26: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2004-2011 57Figure 27: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2011-2018 59Figure 28: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 61Figure 29: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62Figure 30: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 63Figure 31: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 64Figure 32: Interventional Neurology, United States, Company Share (%), 2011 67Figure 33: Neurological Diagnostic Equipment, Market Segmentation 69Figure 34: Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2011 70Figure 35: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2011 71Figure 36: Neurological Diagnostic Equipment, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 72Figure 37: Neurological Diagnostic Equipment, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 74Figure 38: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Historic, 2004-2011 76Figure 39: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Forecast, 2011-2018 78Figure 40: Neurological Diagnostic Equipment, United States, Company Share (%), 2011 82Figure 41: Neurostimulation Devices, Market Segmentation 84Figure 42: Neurostimulation Devices Market, United States, Revenue Mix ($m), 2011 85Figure 43: Neurostimulation Devices Market, United States, Segment Contribution (%), 2011 86Figure 44: Neurostimulation Devices, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 87Figure 45: Neurostimulation Devices, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 89Figure 46: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2004-2011 91Figure 47: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018 93Figure 48: Neurostimulation Devices, United States, Company Share (%), 2011 97Figure 49: Neurosurgical Products, Market Segmentation 98Figure 50: Neurosurgical Products Market, United States, Revenue Mix ($m), 2011 99Figure 51: Neurosurgical Products Market, United States, Segment Contribution (%), 2011 100Figure 52: Neurosurgical Products, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 101Figure 53: Neurosurgical Products, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 103Figure 54: Neurosurgical Products, United States, Volume (Units) by Segment, Historic, 2004-2011 105Figure 55: Neurosurgical Products, United States, Volume (Units) by Segment, Forecast, 2011-2018 106Figure 56: Neurosurgical Products, United States, Company Share (%), 2011 108Figure 57: Radiosurgery, Market Segmentation 110Figure 58: Radiosurgery Market, United States, Revenue Mix ($m), 2011 111Figure 59: Radiosurgery Market, United States, Segment Contribution (%), 2011 112Figure 60: Radiosurgery, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 113Figure 61: Radiosurgery, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 115Figure 62: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2004-2011 117Figure 63: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2011-2018 118Figure 64: Radiosurgery, United States, Company Share (%), 2011 120Figure 65: Medtronic, Inc., Company Share (%),United States Neurology Devices Market, 2011 121Figure 66: Boston Scientific Corporation, Company Share (%),United States Neurology Devices Market, 2011 122Figure 67: St. Jude Medical, Inc., Company Share (%),United States Neurology Devices Market, 2011 123Figure 68: Cyberonics, Inc., Company Share (%),United States Neurology Devices Market, 2011 124Figure 69: DePuy, Inc., Company Share (%),United States Neurology Devices Market, 2011 125Figure 70: Stryker Corporation, Company Share (%),United States Neurology Devices Market, 2011 126